Mannkind (MNKD) EBT Margin (QoQ) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.00 |
| Dec 31, 2025 | -2,817.00 |
| Sep 30, 2025 | 825.00 |
| Jun 30, 2025 | -1,615.00 |
| Mar 31, 2025 | 638.00 |
| Dec 31, 2024 | -737.00 |
| Sep 30, 2024 | 2,070.00 |
| Jun 30, 2024 | -1,878.00 |
| Mar 31, 2024 | 1,137.00 |
| Dec 31, 2023 | 171.00 |
| Sep 30, 2023 | 1,419.00 |
| Jun 30, 2023 | 1,328.00 |
| Mar 31, 2023 | 2,566.00 |
| Dec 31, 2022 | -580.00 |
| Sep 30, 2022 | 963,037.00 |
| Jun 30, 2022 | -945,754.00 |
| Mar 31, 2022 | 742.00 |
| Dec 31, 2021 | -20,429.00 |
| Sep 30, 2021 | 13,266.00 |
| Jun 30, 2021 | -7,851.00 |
| Mar 31, 2021 | 6,913.00 |
| Dec 31, 2020 | -6,847.00 |
| Sep 30, 2020 | 505,127.00 |
| Jun 30, 2020 | -506,858.00 |
| Mar 31, 2020 | 2,639.00 |
| Dec 31, 2019 | 139,762.00 |
| Sep 30, 2019 | 471,207.00 |
| Jun 30, 2019 | -610,820.00 |
| Mar 31, 2019 | -4,024.00 |
| Dec 31, 2018 | 49,574.00 |
| Sep 30, 2018 | 3,550.00 |
| Jun 30, 2018 | 30,062.00 |
| Mar 31, 2018 | -266,380.00 |
| Dec 31, 2017 | 339,658.00 |
| Sep 30, 2017 | 2,410.00 |
| Jun 30, 2017 | -109,129.00 |
| Mar 31, 2017 | -97,764.00 |
| Dec 31, 2016 | 35,721.00 |